Showing results (781-790 of 1,873) with videos related to

Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|October 11, 2020
Methacholine-induced cough as an indicator of bronchodilator-responsive coughNoriyuki Ohkura, Masaki Fujimura, Johsuke Hara, et al.
Pulmonary Pharmacology & Therapeutics|November 30, 2019
Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case seriesRussell P Simon, Clara Oromendia, Lourdes M Sanso, et al.
Pulmonary Pharmacology & Therapeutics|December 1, 2020
An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinilFranck F Rahaghi, Roblee P Allen, Vijay P Balasubramanian, et al.
Pulmonary Pharmacology & Therapeutics|January 29, 2020
Asthmatic children and MDI verbal inhalation technique counselingMarwa O Elgendy, Amira H Hassan, Haitham Saeed, et al.
Pulmonary Pharmacology & Therapeutics|June 30, 2016
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Pulmonary Pharmacology & Therapeutics|February 26, 2016
Effects of low- versus high-dose fluticasone propionate/formoterol fumarate combination therapy on AMP challenge in asthmatic patients: A double-blind, randomised clinical trialFrank Kanniess, Zuzana Diamant, Mark Lomax
Pulmonary Pharmacology & Therapeutics|September 2, 2020
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patientsReed B Hogan Ii, Reed B Hogan Iii, Tim Cannon, et al.
Pulmonary Pharmacology & Therapeutics|November 5, 2020
Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjectsYing Huang, Pryseley Nkouibert Assam, Cong Feng, et al.
Pulmonary Pharmacology & Therapeutics|September 19, 2020
LncRNA STARD13-AS blocks lung squamous carcinoma cells growth and movement by targeting miR-1248/C3AGuosen Li, Xiangyun Guo
Pulmonary Pharmacology & Therapeutics|November 2, 2020
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohortDanilo Di Bona, Elena Minenna, Marcello Albanesi, et al.
Pageof 188